Haleon (HLN) Change in Account Payables (2022 - 2023)
Haleon (HLN) posted Change in Account Payables of $127.8 million for Q4 2023, down 24.31% on a QoQ basis from $168.9 million in Q4 2022, and down 24.31% year-over-year from $168.9 million in Q4 2022.
Haleon (HLN) Change in Account Payables (2022 - 2023) Analysis & Trends
Haleon's Change in Account Payables history runs 2 years deep, the most recent figure standing at $127.8 million for Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 30.60 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 127.84 Mn |
| Dec 31, 2023 | 127.84 Mn |
| Dec 31, 2022 | 168.90 Mn |
| Dec 31, 2022 | 168.90 Mn |